Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Botanical medicines--the need for new regulations.

Marcus DM, Grollman AP.

N Engl J Med. 2002 Dec 19;347(25):2073-6. No abstract available.

PMID:
12490692
2.

Botanical drugs: a future for herbal medicines.

Li W.

J Contemp Health Law Policy. 2002 Winter;19(1):117-49. No abstract available.

PMID:
12733224
3.

Herbal medicine.

McGuffin M.

N Engl J Med. 2003 Apr 10;348(15):1498-501; author reply 1498-501. No abstract available.

PMID:
12691063
4.

Impact of new regulations for pediatric labeling by the Food and Drug Administration.

Buck ML.

Pediatr Nurs. 2000 Jan-Feb;26(1):95-6. No abstract available.

PMID:
12026326
5.

Herbal medicine.

Wollschlaeger BA.

N Engl J Med. 2003 Apr 10;348(15):1498-501; author reply 1498-501. No abstract available.

PMID:
12691064
6.

Herbal medicine in Europe--relaxing regulatory standards.

De Smet PA.

N Engl J Med. 2005 Mar 24;352(12):1176-8. No abstract available.

PMID:
15788494
7.

Safety assessment of newly marketed herbal medicines--methodological approach (Ginkgo biloba example in Bulgaria).

Getov IN, Tzenova AT, Ristoff MS, Todorov TV, Petrova GI.

J Herb Pharmacother. 2007;7(3-4):239-57.

PMID:
18928145
8.

Dosing botanical medicines.

Yarnell E.

J Herb Pharmacother. 2005;5(1):73-8. No abstract available.

PMID:
16093237
9.

Herbal medicine.

Lipman MM.

N Engl J Med. 2003 Apr 10;348(15):1498-501; author reply 1498-501. No abstract available.

10.

Regulatory experts debate FDA's authority.

Young D.

Am J Health Syst Pharm. 2007 May 1;64(9):910, 912. No abstract available.

PMID:
17468140
11.

Phytotherapy and quality of herbal medicines.

Capasso R, Izzo AA, Pinto L, Bifulco T, Vitobello C, Mascolo N.

Fitoterapia. 2000 Aug;71 Suppl 1:S58-65. Review.

PMID:
10930714
12.

Prescribing herbal medications appropriately.

Ernst E.

J Fam Pract. 2004 Dec;53(12):985-8. Review. No abstract available.

PMID:
15581442
13.

Flight 483 now boarding.

Czap A.

Altern Med Rev. 2010 Sep;15(3):183-5. No abstract available.

14.

Scientific reporting of unscientific data--a case of Ginkgo biloba being miscredited.

Bruhn JG; ESCOP Board of Directors; ESCOP Scientific Committee.

Phytomedicine. 2003 May;10(4):358. No abstract available.

PMID:
12809368
16.

"Black Box" warning labels and drug withdrawals.

Thomas JA.

Toxicol Appl Pharmacol. 2002 Sep 1;183(2):81. No abstract available.

PMID:
12387746
17.

[Clinical phytotherapy: opportunities and problematics].

Firenzuoli F, Gori L, Neri D.

Ann Ist Super Sanita. 2005;41(1):27-33. Review. Italian.

18.
19.

FDA prohibits extralabel use of two drug classes.

[No authors listed]

J Am Vet Med Assoc. 1997 Aug 1;211(3):269. No abstract available.

PMID:
9262656
20.

Pin the tail on the other donkey: allocating and avoiding injury losses after drug or device approval.

O'Reilly JT.

Food Drug Law J. 2007;62(3):559-72. No abstract available.

PMID:
17915397

Supplemental Content

Support Center